Oncology

NEBIVOLOL

  • Brand NameXELOBINE
  • Strength500 mg, 150 mg
  • Dosage typeTablets
  • therapeutic areaOncology

INDICATION

  • Adjuvant Colon Cancer - Patients with Duke's C colon cancer, Metastatic Colorectal Cancer - First line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred, Metastatic Breast Cancer - In combination with docetaxel after failure of prior anthracycline containing therapy, As monotherapy in patients resistant to both paclitaxel and an anthracycline containing regimen